Consumption, phthisis, the white plague—a killer by any other name, tuberculosis (TB) has stalked humanity since at least the ...

A live-attenuated tuberculosis (TB) vaccine candidate in development at Texas Biomedical Research Institute (Texas Biomed) ...

The vaccine candidate, being developed by Professor Deepak Kaushal, Ph.D., involves a weakened or “attenuated” strain of Mycobacterium tuberculosis (Mtb), the bacterium that causes TB.

IC31 did not reduce the risk of recurrent disease in individuals who completed treatment for pulmonary tuberculosis.

The current status of TB vaccine development and testing is very encouraging. Several new TB vaccines are currently in Phase I or IIa human trials and field sites for eventual Phase III efficacy ...

Xin Wang et al, Engineered Mycobacterium tuberculosis triple-kill-switch strain provides controlled tuberculosis infection in animal models, Nature Microbiology (2025). DOI: 10.1038/s41564-024-01913-5 ...

Tuberculosis remains one of the most lethal infectious diseases caused by a single pathogen. According to the latest global ...

Henry "Rique" Campa III, a professor of wildlife ecology in Michigan State University's Department of Fisheries and Wildlife, came up with the idea of testing TB vaccination of wild deer in the ...